Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems Opens Australian IPO

NEW YORK, Aug. 30 (GenomeWeb News) - Proteome Systems announced last week the opening of its AU$20 million initial public offering on the Australian Stock Exchange. The offer price, said Proteome Systems, gives the company a market capitalization of AU$120 million.


The size of the IPO is significantly less than Proteome Systems had initial hoped for. As reported earlier this year by ProteoMonitor, GenomeWeb News' sister publication, the company had originally planned to raise AU$45 million, a figure later cut to AU$35 million.


According to Proteome Systems, Patersons Securities is underwriting the offering.


The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.